Skip to content

Healthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy

Healthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06893731
Enrollment
15764
Registered
2025-03-25
Start date
2017-03-01
Completion date
2026-02-01
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathies, Cost

Brief summary

Cardiomyopathy is the most common inherited cardiovascular disease, showing family aggregation, and it has a huge psychological and economic burden on family members. In this study, the investigators collected clinical information and costs of patients hospitalized with cardiomyopathy and establish a database to characterize real-world cost profile and inform cost management of cardiomyopathy.

Detailed description

This study conducted a retrospective survey of hospitalized patients with cardiomyopathy aged ≥18 years in 13 centers in China from March 1, 2017 to March1, 2022. The investigators collected clinical information, healthcare utilization and cost data of patients hospitalized with cardiomyopathy so as to characterize real-world cost profile and inform cost management of cardiomyopathy in China.

Interventions

None listed

Sponsors

China National Center for Cardiovascular Diseases
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospitalized patients with primary discharge diagnosis meeting one of the following subtypes of cardiomyopathy were enrolled, including HCM, DCM, ACM, RCM, left ventricular non-compaction, cardiac amyloidosis, Fabry disease, Pompe disease, Danon disease, and PRKAG2 cardiac syndrome.

Exclusion criteria

* Records with a "likely" or "probable" diagnosis of cardiomyopathy were excluded.

Design outcomes

Primary

MeasureTime frameDescription
total cost per hospital admissionthrough hospitalization completion, an average of 10 daysTotal cost per hospital admissionin is total expenditures made towards a given hospital admission, including the portion paid by the health plan and any out-of-pocket costs paid by enrollees under the plan's cost sharing.The composition of the total cost of hospitalization by categorizing itemized costs into the following groups: total medical consumables cost, total diagnosis-related cost, total treatment cost (e.g., cost of operation), total Western medicine cost, total services cost, total blood and blood products cost, total traditional Chinese medicine cost, total traditional Chinese treatment cost, total rehabilitation cost, and other costs.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026